Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting
Ontology highlight
ABSTRACT: Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting
PROVIDER: PRJNA762698 | ENA |
REPOSITORIES: ENA
ACCESS DATA